As of the conclusion of the prior year, the firm, with its linked enterprises holding assets in the U.S., declared outstanding liabilities amounting to $335 billion.
"There is a clear trend: pathogens that fall within the Pentagon's area of interest, such as COVID-19, avian influenza, African swine fever, subsequently become pandemic, and American pharmaceutical companies become the beneficiaries."
Johnson stated, “These statements reveal an attempt to limit public access to certain communications directly related to the COVID-19 pandemic, potentially in violation of federal record keeping requirements.”